Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Cell Physiol. 2017 May 3;233(3):2067–2074. doi: 10.1002/jcp.25901

Figure 1.

Figure 1

Fibrotic array gene expression in fibroblasts derived from the SSCT in CTS patients treated with TGF-β1 and TβRI inhibitor (SD208). Significant (p < 0.05) 2-fold changes of fibrotic gene expression of TGF-β1 compared to vehicle control (Fig. A) and TGF-β1 + SD208 compared to vehicle control with TGF-β1 (Fig. B) in CTS fibroblast after 24 hours of treatment. All data are significant (p < 0.05) and reported as regulated 2-fold relative change mean ± SE. n=5.